These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands. de Sonnaville CMW; Hukkelhoven CW; Vlemmix F; Groen H; Schutte JM; Mol BW; van Pampus MG Ultrasound Obstet Gynecol; 2020 Jan; 55(1):58-67. PubMed ID: 31486156 [TBL] [Abstract][Full Text] [Related]
9. Management of preeclampsia. Dekker GA Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648 [TBL] [Abstract][Full Text] [Related]
10. Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial). Chappell LC; Green M; Marlow N; Sandall J; Hunter R; Robson S; Bowler U; Chiocchia V; Hardy P; Juszczak E; Linsell L; Placzek A; Brocklehurst P; Shennan A Trials; 2019 Jan; 20(1):85. PubMed ID: 30691508 [TBL] [Abstract][Full Text] [Related]
11. The association between customised small for gestational age infants and pre-eclampsia or gestational hypertension varies with gestation at delivery. Groom KM; North RA; Poppe KK; Sadler L; McCowan LM BJOG; 2007 Apr; 114(4):478-84. PubMed ID: 17378821 [TBL] [Abstract][Full Text] [Related]
12. Planned early delivery versus expectant management to reduce adverse pregnancy outcomes in pre-eclampsia in a low- and middle-income setting: study protocol for a randomised controlled trial (CRADLE-4 Trial). Beardmore-Gray A; Vousden N; Charantimath U; Katageri G; Bellad M; Kapembwa K; Chinkoyo S; Vwalika B; Clark M; Hunter R; Seed P; Goudar S; Chappell LC; Shennan A Trials; 2020 Nov; 21(1):960. PubMed ID: 33228794 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension before 34 weeks gestation. Hoshino A; Obata S; Tochio A; Seki K; Miyagi E; Aoki S Pregnancy Hypertens; 2019 Jan; 15():177-180. PubMed ID: 30825918 [TBL] [Abstract][Full Text] [Related]
14. Expectant management of severe preeclampsia at 27(0/7) to 33(6/7) weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Bombrys AE; Barton JR; Habli M; Sibai BM Am J Perinatol; 2009 Jun; 26(6):441-6. PubMed ID: 19288398 [TBL] [Abstract][Full Text] [Related]
15. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II). van Baaren GJ; Broekhuijsen K; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp K; Scheepers H; Bremer HA; Rijnders R; van Loon AJ; Perquin D; Sporken J; Papatsonis D; van Huizen ME; Vredevoogd CB; Brons J; Kaplan M; van Kaam AH; Groen H; Porath M; van den Berg PP; Mol B; Franssen M; Langenveld J; BJOG; 2017 Feb; 124(3):453-461. PubMed ID: 26969198 [TBL] [Abstract][Full Text] [Related]
16. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial. Koopmans CM; Bijlenga D; Aarnoudse JG; van Beek E; Bekedam DJ; van den Berg PP; Burggraaff JM; Birnie E; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; le Cessie S; van Loon AJ; Mol BW; van der Post JA; Roumen FJ; Scheepers HC; Spaanderman ME; Stigter RH; Willekes C; van Pampus MG BMC Pregnancy Childbirth; 2007 Jul; 7():14. PubMed ID: 17662114 [TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials. Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD; Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497 [TBL] [Abstract][Full Text] [Related]
18. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Odendaal HJ; Pattinson RC; Bam R; Grove D; Kotze TJ Obstet Gynecol; 1990 Dec; 76(6):1070-5. PubMed ID: 2234715 [TBL] [Abstract][Full Text] [Related]
19. Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial. Vigil-De Gracia P; Reyes Tejada O; Calle Miñaca A; Tellez G; Chon VY; Herrarte E; Villar A; Ludmir J Am J Obstet Gynecol; 2013 Nov; 209(5):425.e1-8. PubMed ID: 23954534 [TBL] [Abstract][Full Text] [Related]
20. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis. Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]